Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Inflamm Bowel Dis. 2011 Aug 29;18(4):613–623. doi: 10.1002/ibd.21843

Figure 3.

Figure 3

Effect of resveratrol on fibrosis as assessed by gross abdominal score. Resveratrol (20, 40, or 100 mg/kg/d) or vehicle was given by daily gavage on d1-27 post-injection to PG-PS-and HSA-injected rats. The animals were euthanized on d28. A.) Gross abdominal scores were calculated [the sum of the scores (each on 0–4 scales) for adhesions, mesenteric thickening and contraction, cecal wall thickening, cecal granulomas, and liver granulomas; maximum possible score is 20]. (Results shown are means; n=4–6/group; error bars reflect SEM.) B.) Results are shown as the mean percent decrease in gross abdominal score in PG-PS-injected animals that were treated with resveratrol relative to PG-PS-injected animals given vehicle.